HRAS and colonic neoplasm: In gastric cancer cells and colon cancer cells with hypomethylated c-myc and h-ras promoters, treatment with SAM resulted in increased promoter methylation and consequent downregulation of mRNA and protein levels of c-myc and h-ras [45].